Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-28 · accession 0001610717-23-000427 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-28 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $11.48 | +8,334 | 285.7K | +3% | +$95.7K |
| D | 2023-12-29 | 2023-12-28 | TXG | Hindson Benjamin J. | See Remarks, Dir | M - OptEx | $0.00 | -8,334 | 15.0K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-12-28 | M | A | 8,334 | $11.48 | 285,672 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2023-12-28 | M | D | 8,334 | $0.00 | 14,978 | D | $11.48 · — to 2029-05-10 | 8,334 Class A Common Stock | (F1) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |